Bausch Health Stock Down 11%: Now What? (NYSE:BHC)
Bausch Health’s second leg down in 2022 is a disappointment for shareholders. Read why uncertainty will continue to weigh on BHC stock.
United States Bausch Pharma Thomas Appio Us District Court Bausch Health Abbreviated New Drug Application
Source: seekingalpha.com